Find stats on top websites
Major Markets
Axonics positions itself as the leader in patient-friendly Sacral Neuromodulation, offering the only truly recharge-free SNM system for bladder and bowel dysfunction. They empower patients with lasting relief and improved quality of life.
Customer sentiment appears to be positive and hopeful, as patients are actively seeking effective, long-term solutions after failed traditional treatments. They are motivated to engage and qualify for Axonics' advanced therapy, indicating a high level of trust and interest.
Axonics' key value proposition is providing a 'TRULY Recharge-Free SNM System' that offers long-term, effective relief from bladder and bowel dysfunction. This innovation significantly improves patient convenience and quality of life by eliminating the need for frequent device recharging.
Truly recharge-free SNM system is a key differentiator.
Dual focus on patients and healthcare professionals.
Strong lead generation via qualification quiz.
Backed by Boston Scientific, implying strong R&D and market reach.
Relies on patient and physician education for adoption.
Limited public information on product specifications beyond 'recharge-free'.
Potential challenges integrating into a larger corporate structure.
Expand market share against competitors with rechargeable devices.
Address a large patient population dissatisfied with current treatments.
Leverage Boston Scientific's network for broader market penetration.
Educate public on SNM benefits and Axonics' unique features.
Intense competition from established players like Medtronic.
Regulatory hurdles and evolving healthcare policies.
Dependence on physician adoption and surgical facility availability.
Potential for new, more advanced technologies to emerge.
Axonics primarily targets the US and Canada, reflecting a strong North American presence. They also have a notable international reach in Australia and parts of Europe.
United States
65% market share
Canada
15% market share
Australia
7% market share
Germany
5% market share
United Kingdom
3% market share
35-79 years
Male • Female
United States • Canada • Australia • Europe
65-80 years
Male • Female
United States • Canada
30-60 years
Female
United States • Europe
35-65 years
Male
United States • Canada
30-65 years
Male • Female
United States • Canada • Australia • Europe
Data shown in percentage (%) of usage across platforms
Implement an interactive quiz on the Axonics website to help potential patients determine if they are suitable candidates for the Axonics system. This allows Axonics to pre-qualify leads, personalize the user experience, and streamline the patient journey towards connecting with a healthcare provider.
Learn moreTailor the call-to-action (CTA) on various content pieces (blog posts, social media updates, etc.) to align with the content's specific topic and the user's stage in the buyer journey. For Axonics, this means ensuring that users are presented with relevant next steps, such as 'Find a Doctor', 'Learn More About OAB', or 'Take the Qualification Quiz' based on what they are currently reading.
Learn moreDevelop a personalized onboarding experience for new users who engage with Axonics' online resources, especially after completing the qualification quiz. This can involve tailored content, email sequences, and resource recommendations based on their individual needs and responses, improving engagement and conversion rates.
Learn moreSign up now and unleash the power of AI for your business growth